ASST vs. SKYE

Last updated Jun 9, 2026

ASST (Asset Entities Inc. Class B Common Stock) and SKYE (Skye Bioscience, Inc) are both stocks. ASST operates in Internet Content & Information (Communication Services), while SKYE operates in Biotechnology (Healthcare). Over the past 3 years, ASST returned -49.05%/yr vs -41.13%/yr for SKYE. At a 0.11 correlation, their price movements are largely independent.

Performance

ASST vs. SKYE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Asset Entities Inc. Class B Common Stock (ASST) and Skye Bioscience, Inc (SKYE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ASST achieves a 3.05% return, which is significantly higher than SKYE's 2.71% return.

ASST

• 1D: 9.27%
• 1M: -4.46%
• YTD: 3.05%
• 6M: -22.78%
• 1Y: -86.80%
• 3Y*: -49.05%
• 5Y*: —
• 10Y*: —

SKYE

• 1D: 5.02%
• 1M: -10.75%
• YTD: 2.71%
• 6M: -36.36%
• 1Y: -68.31%
• 3Y*: -41.13%
• 5Y*: -54.71%
• 10Y*: -40.24%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ASST vs. SKYE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ASST Asset Entities Inc. Class B Common Stock	3.05%	50.46%	-84.65%	-82.00%
SKYE Skye Bioscience, Inc	2.71%	-73.51%	4.04%	-76.09%

Correlation

The correlation between ASST and SKYE is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (All Time) Calculated using the full available price history since Feb 6, 2023	0.11

The correlation between ASST and SKYE shifts across timeframes, from 0.11 (all time) to 0.25 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ASST : $937.39M SKYE : $30.55M
EPS ASST : -$25.54 SKYE : -$1.45
Total Revenue (TTM) ASST : $5.73M SKYE : $0.00
Gross Profit (TTM) ASST : -$7.43M SKYE : -$180.01K
EBITDA (TTM) ASST : -$304.63M SKYE : $10.92M

Return for Risk

ASST vs. SKYE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASST

ASST Risk / Return Rank: 15
ASST Sharpe Ratio Rank: 19
ASST Sortino Ratio Rank: 16
ASST Omega Ratio Rank: 18
ASST Calmar Ratio Rank: 6
ASST Martin Ratio Rank: 18

SKYE

SKYE Risk / Return Rank: 19
SKYE Sharpe Ratio Rank: 16
SKYE Sortino Ratio Rank: 22
SKYE Omega Ratio Rank: 21
SKYE Calmar Ratio Rank: 12
SKYE Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASST vs. SKYE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Asset Entities Inc. Class B Common Stock (ASST) and Skye Bioscience, Inc (SKYE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ASST	SKYE	Difference
Sharpe ratio: Return per unit of total volatility	-0.53	-0.59	+0.07
Sortino ratio: Return per unit of downside risk	-0.75	-0.44	-0.31
Omega ratio: Gain probability vs. loss probability	0.92	0.94	-0.02
Calmar ratio: Return relative to maximum drawdown	-0.91	-0.78	-0.13
Martin ratio: Return relative to average drawdown	-1.12	-1.04	-0.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ASST vs. SKYE - Sharpe Ratio Comparison

The current ASST Sharpe Ratio is -0.53, which is comparable to the SKYE Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of ASST and SKYE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ASST	SKYE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.53	-0.59	+0.07
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.42	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.19	-0.36	+0.17

Drawdowns

ASST vs. SKYE - Drawdown Comparison

The maximum ASST drawdown since its inception was -97.98%, roughly equal to the maximum SKYE drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for ASST and SKYE.

Drawdown Indicators

	ASST	SKYE	Difference
Max Drawdown Largest peak-to-trough decline	-97.98%	-99.96%	+1.98%
Max Drawdown (1Y) Largest decline over 1 year	-95.98%	-87.85%	-8.13%
Max Drawdown (3Y) Largest decline over 3 years	-97.25%	-96.79%	-0.46%
Max Drawdown (5Y) Largest decline over 5 years	—	-98.66%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-99.83%	—
Current Drawdown Current decline from peak	-95.72%	-99.94%	+4.22%
Average Drawdown Average peak-to-trough decline	-84.13%	-94.95%	+10.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	77.69%	65.76%	+11.93%

Volatility

ASST vs. SKYE - Volatility Comparison

The current volatility for Asset Entities Inc. Class B Common Stock (ASST) is 26.35%, while Skye Bioscience, Inc (SKYE) has a volatility of 28.64%. This indicates that ASST experiences smaller price fluctuations and is considered to be less risky than SKYE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASST	SKYE	Difference
Volatility (1M) Calculated over the trailing 1-month period	26.35%	28.64%	-2.29%
Volatility (6M) Calculated over the trailing 6-month period	82.30%	63.38%	+18.92%
Volatility (1Y) Calculated over the trailing 1-year period	164.70%	115.33%	+49.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	322.72%	130.81%	+191.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	322.72%	137.31%	+185.41%

Dividends

ASST vs. SKYE - Dividend Comparison

Neither ASST nor SKYE has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ASST and SKYE in my portfolio?

ASST and SKYE have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ASST or SKYE?

SKYE has higher volatility (28.64%) compared to ASST (26.35%). In terms of maximum drawdown, ASST dropped -97.98% vs SKYE's -99.96%.

Which has better risk-adjusted returns?

ASST currently has the higher Sharpe Ratio (-0.53 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.